June 25, 2014 — 1:00-4:00 P.M.
William H. Natcher Conference Center
National Institutes of Health
Bethesda, Maryland, USA
The purpose of the first annual ICCVAM Public Forum was to give stakeholders and members of the public an opportunity to provide ideas and suggestions to representatives of the federal agencies that comprise ICCVAM. The Forum was attended by over 50 in-person and remote participants, who viewed presentations (linked below) by ICCVAM committee members about their agencies’ activities relevant to development and use of alternative test methods. Public comments were also presented by representatives of groups interested in promoting alternative methods or reducing animal use in testing. Key points raised included requests for increased transparency in reporting animal use by industry and to ensure adequate training for reviewers at regulatory agencies on available non-animal methods and strategies.
Call to Order and Introductions
Dr. Warren Casey, NICEATM
Dr. Abby Jacobs, FDA, ICCVAM Co-Chair
Dr. Anna Lowit, EPA, ICCVAM Co-Chair
ICCVAM Agency Updates
Public Attendee Presentations